These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38560365)
1. Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitus. Babatunde D; Pollock AM; Ocan M; Brhlikova P JRSM Open; 2024 Mar; 15(3):20542704241232814. PubMed ID: 38560365 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the implementation of the standard treatment guidelines (STGs) and essential medicines list (EML) at a public South African tertiary institution and its associated primary health care (PHC) facilities. Govender T; Suleman F; Perumal-Pillay VA J Pharm Policy Pract; 2021 Dec; 14(1):105. PubMed ID: 34906236 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of essential medicines lists: the South African case study. Perumal-Pillay VA; Suleman F BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea. Joshua IB; Passmore PR; Sunderland BV Health Policy Plan; 2016 May; 31(4):538-46. PubMed ID: 26378052 [TBL] [Abstract][Full Text] [Related]
5. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis. Green A; Lyus R; Ocan M; Pollock AM; Brhlikova P J R Soc Med; 2023 Oct; 116(10):331-342. PubMed ID: 37343667 [TBL] [Abstract][Full Text] [Related]
6. Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana. Koduah A; Asare BA; Gavor E; Gyansa-Lutterodt M; Andrews Annan E; Ofei FW Health Policy Plan; 2019 Nov; 34(Supplement_2):ii104-ii120. PubMed ID: 31723963 [TBL] [Abstract][Full Text] [Related]
7. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties. Ashigbie PG; Rockers PC; Laing RO; Cabral HJ; Onyango MA; Buleti JPL; Wirtz VJ BMJ Open; 2020 May; 10(5):e035132. PubMed ID: 32414824 [TBL] [Abstract][Full Text] [Related]
8. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018. Lyus R; Pollock A; Ocan M; Brhlikova P Bull World Health Organ; 2020 Aug; 98(8):530-538. PubMed ID: 32773898 [TBL] [Abstract][Full Text] [Related]
9. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list. Naicker I; Suleman F; Perumal-Pillay VA J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421 [TBL] [Abstract][Full Text] [Related]
10. Drawing lessons from the standard treatment guidelines and essential medicines list concept in South Africa as the country moves towards national health insurance. Perumal-Pillay VA; Suleman F S Afr Fam Pract (2004); 2021 Jan; 63(1):e1-e3. PubMed ID: 33567840 [TBL] [Abstract][Full Text] [Related]
11. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda. Baldeh AO; Millard C; Pollock AM; Brhlikova P J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists. Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195 [TBL] [Abstract][Full Text] [Related]
15. The role of government agencies and other actors in influencing access to medicines in three East African countries. Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583 [TBL] [Abstract][Full Text] [Related]
16. Essential medicines for children in Armenia. Kazaryan I; Vardanyan L Int J Risk Saf Med; 2015; 27 Suppl 1():S43-4. PubMed ID: 26639704 [TBL] [Abstract][Full Text] [Related]
17. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950 [TBL] [Abstract][Full Text] [Related]
18. Essential drugs programmes in Africa. Laing R Afr Health; 1991 Nov; 14(1):32-3. PubMed ID: 12343453 [TBL] [Abstract][Full Text] [Related]
19. Keeping essential reproductive, maternal and child health services available during COVID-19 in Kenya, Mozambique, Uganda and Zimbabwe: analysis of early-pandemic policy guidelines. Plotkin MK; Williams KM; Mbinda A; Oficiano VN; Nyauchi B; Walugembe P; Keyes E; Rawlins B; McCarraher D; Chabikuli ON BMC Public Health; 2022 Mar; 22(1):577. PubMed ID: 35321675 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of standard treatment guidelines in India. Koli PG; Kshirsagar NA; Shetty YC; Mehta D; Mittal Y; Parmar U Indian J Med Res; 2019 Jun; 149(6):715-729. PubMed ID: 31496524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]